KMPR

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2002, for Unitrin, Inc. (Note: The filing metadata lists "KEMPER Corp," but the document text identifies the registrant as Unitrin, Inc., which is acquiring a business unit from Kemper). Unitrin operates through five segments: Multi Lines Insurance, Specialty Lines Insurance, Life and Health Insurance, Consumer Finance, and Unitrin Direct. The company adopted SFAS No. 142 (Goodwill) on January 1, 2002, ceasing goodwill amortization.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased by $44.1 million (9.4%) driven by a $45.6 million increase in premiums, primarily in Specialty Lines ($29.7M increase) and Multi Lines ($6.9M increase).
• Profit Decline: Net income decreased by $7.4 million (44.6%). This was primarily due to a $7.9 million swing in "Equity in Net Income (Loss) of Investees," which turned from a $5.2 million gain in 2001 to a $2.7 million loss in 2002, largely attributed to UNOVA, Inc.
• Investment Income: Net investment income decreased slightly by $1.4 million due to lower yields, despite higher investment levels.
• Segment Performance:
  • Multi Lines: Operating profit turned negative ($-6.8M) from a profit of $3.1M due to higher non-storm losses and lower investment income.
  • Specialty Lines: Operating profit improved to $0.7M from a loss of $3.5M, aided by higher premiums and improved loss ratios.
  • Life & Health: Operating profit increased to $23.2M from $21.7M.
  • Unitrin Direct: Operating loss widened to $7.7M from $4.1M due to upfront marketing costs.
• Accounting Change: The adoption of SFAS No. 142 eliminated goodwill amortization expense, which previously reduced net income by approximately $1.9 million in the prior year.

Outlook, Risks, and Unusual Items

• Acquisition: On April 19, 2002, Unitrin agreed to acquire the personal lines business of Kemper Insurance Companies for approximately $45 million plus performance-based bonuses. The transaction is subject to regulatory approval.
• Legal Proceedings: The company faces a nationwide class action lawsuit regarding alleged racial discrimination in industrial life insurance pricing. While the company recorded a liability in 2000, it notes that actual costs could materially affect results in a given period.
• Investee Volatility: The company's equity earnings are heavily influenced by UNOVA, Inc., which reported a loss of $2.7 million in Q1 2002. Unitrin also holds significant equity positions in Northrop Grumman and Baker Hughes.
• Market Risk: A 100 basis point increase in interest rates would decrease the fair value of fixed maturities by approximately $149.4 million. A 10% drop in the S&P 500 would decrease the fair value of equity securities by approximately $82.9 million.
• Liquidity: The company has a $440 million revolving credit facility with $186 million unused. It anticipates replacing this facility before its September 2002 expiration.

Investor Verification Checklist

• Verify the status and regulatory approval of the pending acquisition of Kemper's personal lines business.
• Monitor the financial performance of UNOVA, Inc., as its losses significantly impacted Q1 2002 net income.
• Review the development of loss reserves, particularly in the Multi Lines segment, which turned unprofitable due to higher non-storm losses.
• Assess the progress of the Unitrin Direct segment, which is expected to remain unprofitable for several years due to high acquisition costs.
• Track the resolution of the industrial life insurance class action litigation and potential changes to the recorded liability.